The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Leukocyte Antigen (HLA) Testing Market Research Report 2025
Synopsis
A blood test equipment that identifies antigens on the surface of cells and tissues.
The global Human Leukocyte Antigen (HLA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen (HLA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen (HLA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Leukocyte Antigen (HLA) Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Leukocyte Antigen (HLA) Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen (HLA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen (HLA) Testing.
Report Scope
The Human Leukocyte Antigen (HLA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen (HLA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen (HLA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Segment by Application
Hospital
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Leukocyte Antigen (HLA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A blood test equipment that identifies antigens on the surface of cells and tissues.
The global Human Leukocyte Antigen (HLA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen (HLA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen (HLA) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Leukocyte Antigen (HLA) Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Leukocyte Antigen (HLA) Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen (HLA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen (HLA) Testing.
Report Scope
The Human Leukocyte Antigen (HLA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen (HLA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen (HLA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Segment by Application
Hospital
Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Leukocyte Antigen (HLA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Market by Application
1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Leukocyte Antigen (HLA) Testing Market Perspective (2019-2030)
2.2 Human Leukocyte Antigen (HLA) Testing Growth Trends by Region
2.2.1 Global Human Leukocyte Antigen (HLA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Leukocyte Antigen (HLA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Human Leukocyte Antigen (HLA) Testing Market Dynamics
2.3.1 Human Leukocyte Antigen (HLA) Testing Industry Trends
2.3.2 Human Leukocyte Antigen (HLA) Testing Market Drivers
2.3.3 Human Leukocyte Antigen (HLA) Testing Market Challenges
2.3.4 Human Leukocyte Antigen (HLA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Revenue
3.1.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Revenue (2019-2024)
3.1.2 Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Human Leukocyte Antigen (HLA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Leukocyte Antigen (HLA) Testing Revenue
3.4 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio
3.4.1 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Leukocyte Antigen (HLA) Testing Revenue in 2023
3.5 Human Leukocyte Antigen (HLA) Testing Key Players Head office and Area Served
3.6 Key Players Human Leukocyte Antigen (HLA) Testing Product Solution and Service
3.7 Date of Enter into Human Leukocyte Antigen (HLA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Type
4.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Type (2025-2030)
5 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Application
5.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Leukocyte Antigen (HLA) Testing Market Size (2019-2030)
6.2 North America Human Leukocyte Antigen (HLA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024)
6.4 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size (2019-2030)
7.2 Europe Human Leukocyte Antigen (HLA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024)
7.4 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size (2019-2030)
9.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024)
9.4 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 F. Hoffman-La Roche
11.2.1 F. Hoffman-La Roche Company Detail
11.2.2 F. Hoffman-La Roche Business Overview
11.2.3 F. Hoffman-La Roche Human Leukocyte Antigen (HLA) Testing Introduction
11.2.4 F. Hoffman-La Roche Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.2.5 F. Hoffman-La Roche Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Human Leukocyte Antigen (HLA) Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Detail
11.4.2 QIAGEN N.V. Business Overview
11.4.3 QIAGEN N.V. Human Leukocyte Antigen (HLA) Testing Introduction
11.4.4 QIAGEN N.V. Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.4.5 QIAGEN N.V. Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Human Leukocyte Antigen (HLA) Testing Introduction
11.5.4 Illumina Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Immucor
11.6.1 Immucor Company Detail
11.6.2 Immucor Business Overview
11.6.3 Immucor Human Leukocyte Antigen (HLA) Testing Introduction
11.6.4 Immucor Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.6.5 Immucor Recent Development
11.7 CareDx
11.7.1 CareDx Company Detail
11.7.2 CareDx Business Overview
11.7.3 CareDx Human Leukocyte Antigen (HLA) Testing Introduction
11.7.4 CareDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.7.5 CareDx Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Detail
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Human Leukocyte Antigen (HLA) Testing Introduction
11.8.4 Becton Dickinson Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.8.5 Becton Dickinson Recent Development
11.9 Hologic
11.9.1 Hologic Company Detail
11.9.2 Hologic Business Overview
11.9.3 Hologic Human Leukocyte Antigen (HLA) Testing Introduction
11.9.4 Hologic Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.9.5 Hologic Recent Development
11.10 GenDx
11.10.1 GenDx Company Detail
11.10.2 GenDx Business Overview
11.10.3 GenDx Human Leukocyte Antigen (HLA) Testing Introduction
11.10.4 GenDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.10.5 GenDx Recent Development
11.11 Biofortuna
11.11.1 Biofortuna Company Detail
11.11.2 Biofortuna Business Overview
11.11.3 Biofortuna Human Leukocyte Antigen (HLA) Testing Introduction
11.11.4 Biofortuna Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
11.11.5 Biofortuna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Molecular Assay Technologies
Table 3. Key Players of Non-molecular Assay Technologies
Table 4. Global Human Leukocyte Antigen (HLA) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Leukocyte Antigen (HLA) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Leukocyte Antigen (HLA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Leukocyte Antigen (HLA) Testing Market Share by Region (2019-2024)
Table 8. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Leukocyte Antigen (HLA) Testing Market Share by Region (2025-2030)
Table 10. Human Leukocyte Antigen (HLA) Testing Market Trends
Table 11. Human Leukocyte Antigen (HLA) Testing Market Drivers
Table 12. Human Leukocyte Antigen (HLA) Testing Market Challenges
Table 13. Human Leukocyte Antigen (HLA) Testing Market Restraints
Table 14. Global Human Leukocyte Antigen (HLA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Leukocyte Antigen (HLA) Testing Market Share by Players (2019-2024)
Table 16. Global Top Human Leukocyte Antigen (HLA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen (HLA) Testing as of 2023)
Table 17. Ranking of Global Top Human Leukocyte Antigen (HLA) Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Leukocyte Antigen (HLA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Leukocyte Antigen (HLA) Testing Product Solution and Service
Table 21. Date of Enter into Human Leukocyte Antigen (HLA) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Leukocyte Antigen (HLA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Human Leukocyte Antigen (HLA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Testing Product
Table 49. Thermo Fisher Scientific Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. F. Hoffman-La Roche Company Detail
Table 52. F. Hoffman-La Roche Business Overview
Table 53. F. Hoffman-La Roche Human Leukocyte Antigen (HLA) Testing Product
Table 54. F. Hoffman-La Roche Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 55. F. Hoffman-La Roche Recent Development
Table 56. Bio-Rad Laboratories Company Detail
Table 57. Bio-Rad Laboratories Business Overview
Table 58. Bio-Rad Laboratories Human Leukocyte Antigen (HLA) Testing Product
Table 59. Bio-Rad Laboratories Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 60. Bio-Rad Laboratories Recent Development
Table 61. QIAGEN N.V. Company Detail
Table 62. QIAGEN N.V. Business Overview
Table 63. QIAGEN N.V. Human Leukocyte Antigen (HLA) Testing Product
Table 64. QIAGEN N.V. Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 65. QIAGEN N.V. Recent Development
Table 66. Illumina Company Detail
Table 67. Illumina Business Overview
Table 68. Illumina Human Leukocyte Antigen (HLA) Testing Product
Table 69. Illumina Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. Immucor Company Detail
Table 72. Immucor Business Overview
Table 73. Immucor Human Leukocyte Antigen (HLA) Testing Product
Table 74. Immucor Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 75. Immucor Recent Development
Table 76. CareDx Company Detail
Table 77. CareDx Business Overview
Table 78. CareDx Human Leukocyte Antigen (HLA) Testing Product
Table 79. CareDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 80. CareDx Recent Development
Table 81. Becton Dickinson Company Detail
Table 82. Becton Dickinson Business Overview
Table 83. Becton Dickinson Human Leukocyte Antigen (HLA) Testing Product
Table 84. Becton Dickinson Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 85. Becton Dickinson Recent Development
Table 86. Hologic Company Detail
Table 87. Hologic Business Overview
Table 88. Hologic Human Leukocyte Antigen (HLA) Testing Product
Table 89. Hologic Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 90. Hologic Recent Development
Table 91. GenDx Company Detail
Table 92. GenDx Business Overview
Table 93. GenDx Human Leukocyte Antigen (HLA) Testing Product
Table 94. GenDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 95. GenDx Recent Development
Table 96. Biofortuna Company Detail
Table 97. Biofortuna Business Overview
Table 98. Biofortuna Human Leukocyte Antigen (HLA) Testing Product
Table 99. Biofortuna Revenue in Human Leukocyte Antigen (HLA) Testing Business (2019-2024) & (US$ Million)
Table 100. Biofortuna Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Leukocyte Antigen (HLA) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Leukocyte Antigen (HLA) Testing Market Share by Type: 2023 VS 2030
Figure 3. Molecular Assay Technologies Features
Figure 4. Non-molecular Assay Technologies Features
Figure 5. Global Human Leukocyte Antigen (HLA) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Leukocyte Antigen (HLA) Testing Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Human Leukocyte Antigen (HLA) Testing Report Years Considered
Figure 11. Global Human Leukocyte Antigen (HLA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Human Leukocyte Antigen (HLA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Human Leukocyte Antigen (HLA) Testing Market Share by Region: 2023 VS 2030
Figure 14. Global Human Leukocyte Antigen (HLA) Testing Market Share by Players in 2023
Figure 15. Global Top Human Leukocyte Antigen (HLA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen (HLA) Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Human Leukocyte Antigen (HLA) Testing Revenue in 2023
Figure 17. North America Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Human Leukocyte Antigen (HLA) Testing Market Share by Country (2019-2030)
Figure 19. United States Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Leukocyte Antigen (HLA) Testing Market Share by Country (2019-2030)
Figure 23. Germany Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Share by Region (2019-2030)
Figure 31. China Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Leukocyte Antigen (HLA) Testing Market Share by Country (2019-2030)
Figure 39. Mexico Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Share by Country (2019-2030)
Figure 43. Turkey Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 46. F. Hoffman-La Roche Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 48. QIAGEN N.V. Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 49. Illumina Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 50. Immucor Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 51. CareDx Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 52. Becton Dickinson Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 53. Hologic Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 54. GenDx Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 55. Biofortuna Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
